Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCORI Lays Comparative Effectiveness Research Groundwork With Environmental Scans, Tier 1 Grant Process

This article was originally published in The Gray Sheet

Executive Summary

The Patient-Centered Outcomes Research Institute board of governors approved two actions that are expected to form the foundation of the institute's future work: conducting environmental scans and developing the process for awarding “tier 1” grants.

You may also be interested in...



Feds Furnish $100 Million For Device Comparative Effectiveness Research

The Department of Health and Human Services has committed nearly $100 million to device and diagnostics studies out of the $1.1 billion designated by the 2009 economic stimulus package for comparative effectiveness research.

Feds Furnish $100 Million For Device Comparative Effectiveness Research

The Department of Health and Human Services has committed nearly $100 million to device and diagnostics studies out of the $1.1 billion designated by the 2009 economic stimulus package for comparative effectiveness research.

PCORI Methods Panel To Define “Patient-Centered Outcomes Research”

When the Patient-Centered Outcomes Research Institute's Methodology Committee finished its presentation to PCORI's Board of Governors, one thing was clear: the committee is looking for something broader in “patient-centered outcomes research” than simply comparative effectiveness research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029941

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel